Condition: Valve Replacement Surgery · Sponsor: Asan Medical Center
This trial is a multinational, multicenter, randomized, open-label, active-controlled clinical trial comparing the safety of aspirin versus vitamin K antagonists (warfarin) as oral antithrombotic therapy during the initial 6 months following tissue valve replacement (aortic or mitral).
This description comes directly from the study's public registry record.
Joon-bum Kim, MD · 82230105416 · jbkim1975@amc.seoul.kr
Always discuss trial participation with your own doctor first.
| National Cerebral and Cardiovascular Center Hospital | Osaka, Japan | Not Yet Recruiting |
| Osaka University Hospital | Osaka, Japan | Not Yet Recruiting |
| Asan Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07431762